We describe herein a novel FcγR-independent mechanism of platelet clearance in thrombocytopenia mediated predominantly by anti-GPIbα antibodies, which is distinct from Fc-dependent ITP in both mechanism and therapeutic management. This evidence concerns the gene GP1BA and autoimmune thrombocytopenic purpura.